Sean D Keohane Cabot Corp (CBT) insider trading activity

Sean D Keohane is President and CEO of CABOT CORP. Currently has a direct ownership of 331,174 shares of CBT, which is worth approximately $36.1 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 25,617 shares (Common Stock) at a price of $101.76 per share, resulting in proceeds of $2,606,785. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 331K

0% 3M change

1.95% 12M change

Total Value Held $36.1 Million

Sean D Keohane Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Open market or private sale	$2,606,785 $101.76 p/Share	25,617 Reduced 7.18%	331,174 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$1,012,896 $39.54 p/Share	25,617 Added 6.7%	356,791 Common Stock
Mar 01 2024	SELL Open market or private sale	$1,526,416 $85.48 p/Share	17,857 Reduced 5.12%	331,174 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$821,957 $46.03 p/Share	17,857 Added 4.87%	349,031 Common Stock
Nov 20 2023	SELL Payment of exercise price or tax liability	$3,056,325 $77.89 p/Share	39,239 Reduced 10.59%	331,174 Common Stock
Nov 20 2023	BUY Grant, award, or other acquisition	-	37,402 Added 9.17%	370,413 Common Stock
Nov 13 2023	SELL Payment of exercise price or tax liability	$1,245,803 $74.08 p/Share	16,817 Reduced 4.81%	333,011 Common Stock
Nov 10 2023	BUY Grant, award, or other acquisition	-	25,000 Added 6.67%	349,828 Common Stock
Nov 21 2022	SELL Payment of exercise price or tax liability	$1,223,178 $71.51 p/Share	17,105 Reduced 5.0%	324,828 Common Stock
Nov 21 2022	BUY Grant, award, or other acquisition	-	66,196 Added 16.22%	341,933 Common Stock
Nov 11 2022	BUY Grant, award, or other acquisition	-	21,939 Added 7.37%	275,737 Common Stock
Nov 08 2022	SELL Payment of exercise price or tax liability	$835,234 $70.07 p/Share	11,920 Reduced 4.49%	253,798 Common Stock
May 24 2022	SELL Open market or private sale	$989,209 $69.19 p/Share	14,297 Reduced 5.11%	265,718 Common Stock
May 24 2022	BUY Exercise of conversion of derivative security	$680,823 $47.62 p/Share	14,297 Added 4.86%	280,015 Common Stock
Nov 22 2021	SELL Payment of exercise price or tax liability	$554,188 $59.68 p/Share	9,286 Reduced 3.38%	265,718 Common Stock
Nov 22 2021	BUY Grant, award, or other acquisition	-	57,673 Added 17.34%	275,004 Common Stock
Nov 12 2021	BUY Grant, award, or other acquisition	-	24,455 Added 10.11%	217,331 Common Stock
Nov 09 2021	SELL Payment of exercise price or tax liability	$688,922 $57.53 p/Share	11,975 Reduced 5.85%	192,876 Common Stock
Nov 13 2020	BUY Grant, award, or other acquisition	-	34,781 Added 14.51%	204,851 Common Stock
Nov 10 2020	SELL Payment of exercise price or tax liability	$807,466 $43.18 p/Share	18,700 Reduced 9.91%	170,070 Common Stock

Also insider at

Chemours Co Basic Materials

Director

SDK

Sean D Keohane

President and CEO

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBT shares.

Notify only if

Value

Insider Trading

Get notified when an Cabot Corp insider buys or sells CBT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CABOT CORP

Track Activities on CBT

Account